ascendis pharma glp-1 receptor agonist medications Holding Agonists Prior to Elective Procedures Issue 42: GLP-1 RA Drug

For most patients, the most effective longterm strategy after achieving a target weight is to continue GLP1 treatment

doi: 10.1210/endo.139.9.6288 23 SammsRJChristeMECollinsKAPirroVDrozBAHollandAKet al

Even better outcomes in seronegative spondyloarthritis and dramatic improvements in OA pain and function

Indeed, Australian guidelines recommend GLP-1RAs as an add-on option to metformin from the second-line setting (Fig

Other areas of interest, such as potential long-term effects on bone health and fracture risk, are also subjects of ongoing investigation, as significant weight loss can sometimes be associated with changes in bone density